Orphomed
Drug Stores & Pharmacies · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
50 Francisco St Ste 245, San Francisco, ...Phone Number
(415) 888-2264Website
www.orphomed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Orphomed
Domain Coasters is a reputable expired domain marketplace that offers premium domain names for sale, including orphomed.com. They provide secure and verified transactions, ensuring ownership transfer is guaranteed and legally binding. With a customer base of over 3,000 across 80 countries, they facilitate lightning-fast domain transfers within 24 hours. The company prides itself on hassle-free payments with no hidden fees, making the purchasing process straightforward for clients.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orphomed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Orphomed had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Orphomed has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Orphomed is spiking on competitors!
Orphomed, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Orphomed recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Orphomed
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Orphomed launches new products
Check if Orphomed has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Orphomed
Find 2 more new buyers
Compare Similar Companies to Orphomed
Compare insights from companies similar to Orphomed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Orphomed
<$5M
1-10
Private
$42.2M
2015
N/A
$6.5M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Orphomed is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Orphomed is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Orphomed.
Orphomed financials insights
Gather financial insights about Orphomed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$2.8M
2017
Series A
$39M
2020
Debt
$150K
2021
Debt
$190K
Orphomed Tech Stack
A closer look at the technologies used by Orphomed
Orphomed News & Media
OrphoMed’s ORP-101 Passes Second Planned Interim Analysis in Phase 2 Study of Treatment for IBS-D Patients
SAN FRANCISCO--(BUSINESS WIRE)-- #IBS--OrphoMed's ORP-101 molecule passed its second interim analysis in a Phase 2 clinical trial for treatment of IBS with diarrhea (IBS-D).OrphoMed Passes First Interim Analysis in Phase 2 Study of Treatment for IBS-D Patients
SAN FRANCISCO--(BUSINESS WIRE)--OrphoMed's ORP-101 molecule passed its first interim analysis in a Phase 2 clinical trial for treatment of IBS with diarrhea (IBS-D).OrphoMed Resumes Recruitment for Phase 2 Adaptive Design Study of ORP-101 for Treatment of IBS-D
SAN FRANCISCO--(BUSINESS WIRE)-- #clinicaltrial--OrphoMed has resumed recruitment for its Phase 2 adaptive design study of ORP-101 for treatment of IBS-D.OrphoMed Pauses Recruitment for Phase 2 Adaptive Design Study of ORP-101 for Treatment of IBS-D
SAN FRANCISCO--(BUSINESS WIRE)-- #COVID19--OrphoMed, Inc. has paused recruitment for its Phase 2 adaptive design study of ORP-101 for treatment of IBS-D in response to COVID-19.
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orphomed
Sign Up For FreeTo access detailed company insights
Domain Coasters is a reputable expired domain marketplace that offers premium domain names for sale, including orphomed.com. They provide secure and verified transactions, ensuring ownership transfer is guaranteed and legally binding. With a customer base of over 3,000 across 80 countries, they facilitate lightning-fast domain transfers within 24 h... Read More
